IMP-51, a novel IMP-Type Metallo-β-Lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant pseudomonas aeruginosa clinical isolate

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 11, 2015, Pages 7090-7093

  Tada, Tatsuya ^a   Nhung, Pham Hong ^a,b   Miyoshi Akiyama, Tohru ^a   Shimada, Kayo ^a   Phuong, Doan Mai ^b   Anh, Nguyen Quoc ^b   Ohmagari, Norio ^a   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CEFOXITIN; DORIPENEM; HYDROLASE; INOSINE PHOSPHATE; LATAMOXEF; MEROPENEM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; ESCHERICHIA COLI; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VIET NAM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

BETA-LACTAMASES; CARBAPENEMS; CEFOXITIN; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOXALACTAM; PSEUDOMONAS AERUGINOSA; THIENAMYCINS;

EID: 84946227981     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01611-15     Document Type: Article

References (31)

1. Bush K. 2001. New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:1085-1089. http://dx.doi.org/10.1086/319610.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306-325. http://dx.doi.org/10.1128/CMR.18.2.306-325.2005.
3. Bush K, Jacoby GA 2010. Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54:969-976. http://dx.doi.org/10.1128/AAC.01009-09.
4. Cornaglia G, Giamarellou H, Rossolini GM 2011. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 11:381-393. http://dx.doi.org/10.1016/S1473-3099(11)70056-1.
5. AIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother 56:6154-6159. http://dx.doi.org/10.1128/AAC.05654-11.
6. Rogalski TM, Gilbert MM, Devenport D, Norman K.R., Moerman DG 2003. DIM-1, a novel immunoglobulin superfamily protein in Caenorhabditis elegans, is necessary for maintaining bodywall muscle integrity. Genetics 163:905-915.
7. Pollini S, Maradei S, Pecile P., Olivo G, Luzzaro F, Docquier J.D., Rossolini GM. 2013. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 57:410-416. http://dx.doi.org/10.1128/AAC.01953-12.
8. -1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother 48: 4654-4661. http://dx.doi.org/10.1128/AAC.48.12.4654-4661.2004.
9. Osano E, Arakawa Y, Wacharotayankun R., Ohta M, Horii T, Ito H., Yoshimura F, Kato N. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71-78. http://dx.doi.org/10.1128/AAC.38.1.71.
10. Sekiguchi J, Morita K, Kitao T., Watanabe N, Okazaki M, Miyoshi-Akiyama T, Kanamori M., Kirikae T. 2008. KHM-1, a novel plasmidmediated metallo-β-lactamase from a Citrobacterfreundii clinical isolate. Antimicrob Agents Chemother 52:4194-4197. http://dx.doi.org/10.1128/AAC.01337-07.
11. NDM1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
12. Wachino J, Yoshida H, Yamane K., Suzuki S, Matsui M, Yamagishi T., Tsutsui A, Konda T, Shibayama K., Arakawa Y. 2011. SMB-1, a novel subclass B3 metallo-β-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate. Antimicrob Agents Chemother 55:5143-5149. http://dx.doi.org/10.1128/AAC.05045-11.
13. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49:4485-4491. http://dx.doi.org/10.1128/AAC.49.11.4485-4491.2005.
14. Zavascki AP, Gaspareto PB, Martins A.F., Goncalves AL, Barth AL. 2005. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother 56:1148-1151. http://dx.doi.org/10.1093/jac/dki390.
15. El Salabi A., Borra PS, Toleman M.A., Samuelsen O., Walsh TR. 2012. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother 56:2241-2245. http://dx.doi.org/10.1128/AAC.05640-11.
16. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43:1584-1590.
17. Jacoby GA, Munoz-Price LS. 2005. The new β-lactamases. N Engl J Med 352:380-391. http://dx.doi.org/10.1056/NEJMra041359.
18. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. CLSI M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Kitao T, Miyoshi-Akiyama T, Tanaka M., Narahara K, Shimojima M, Kirikae T. 2011. Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-β-lactamases that mediate carbapenem resistance in Pseudomonas. J Microbiol Methods 87:330-337. http://dx.doi.org/10.1016/j.mimet.2011.09.011.
20. Tada T, Miyoshi-Akiyama T, Tanaka M., Narahara K, Shimojima M, Kitao T., Shimada K, Kirikae T. 2012. Development of an immunochromatographic assay for rapid detection of AAC(6')-Ib-producing Pseudomonas aeruginosa. J Microbiol Methods 91:114-116. http://dx.doi.org/10.1016/j.mimet.2012.05.009.
21. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A., Mizuguchi Y, Araake M, Fujino T., Kikuchi H, Sasaki S, Watari H., Kojima T, Miki H, Kanemitsu K., Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T. 2007. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 45:979-989. http://dx.doi.org/10.1128/JCM.01772-06.
22. Tada T, Shrestha B, Miyoshi-Akiyama T, Shimada K., Ohara H, Kirikae T, Pokhrel BM 2014. NDM-12, a novel New Delhi metallo-β-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother 58:6302-6305. http://dx.doi.org/10.1128/AAC.03355-14.
23. Boschi L, Mercuri PS, Riccio M.L., Amicosante G., Galleni M, Frere JM, Rossolini GM 2000. The Legionella (Fluoribacter) gormanii metallo-β-lactamase: a new member of the highly divergent lineage of molecularsubclass B3 β-lactamases. Antimicrob Agents Chemother 44:1538-1543. http://dx.doi.org/10.1128/AAC.44.6.1538-1543.2000.
24. Crowder MW, Walsh TR, Banovic L, Pettit M., Spencer J. 1998. Overexpression, purification, and characterization of the cloned metallo-β-lactamase L1 from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 42:921-926.
25. Queenan AM, Shang W, Flamm R., Bush K. 2010. Hydrolysis and inhibition profiles of β-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob Agents Chemother 54:565-569. http://dx.doi.org/10.1128/AAC.01004-09.
26. Liu SL, Hessel A, Sanderson KE 1993. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad Sci U S A 90:6874-6878. http://dx.doi.org/10.1073/pnas.90.14.6874.
27. Tada T, Miyoshi-Akiyama T, Shimada K., Kirikae T. 2014. Biochemical analysis of the metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob Agents Chemother 58:3538-3540. http://dx.doi.org/10.1128/AAC.02793-13.
28. Xiong J, Alexander DC, Ma J.H., Deraspe M., Low DE, Jamieson FB, Roy PH. 2013. Complete sequence of pOZ176, a 500-kilobase IncP-2 plasmid encoding IMP-9-mediated carbapenem resistance, from outbreak isolate Pseudomonas aeruginosa 96. Antimicrob Agents Chemother 57:3775-3782. http://dx.doi.org/10.1128/AAC.00423-13.
29. Yano H, Kuga A, Okamoto R., Kitasato H, Kobayashi T, Inoue M. 2001. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 45: 1343-1348. http://dx.doi.org/10.1128/AAC.45.5.1343-1348.2001.
30. Pegg KM, Liu EM, George A.C., LaCuran AE, Bethel CR, Bonomo RA, Oelschlaeger P. 2014. Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262. Protein Sci 23:1451-1460. http://dx.doi.org/10.1002/pro.2530.
31. Oelschlaeger P, Schmid RD, Pleiss J. 2003. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-β-lactamases IMP-1 and IMP-6. Biochemistry 42:8945-8956. http://dx.doi.org/10.1021/bi0300332.